Table 1.
Cell line | Peak cell concentration | Specific growth rate | Specific productivity | Yield | STY | Process type | Reference |
---|---|---|---|---|---|---|---|
[106 cells/mL] | [per day] | [pg/cell/day] | [g/L] | [mg/(L × day)] | |||
CHO | 8.5 | 0.7 | >50 | 0.9 | 121 | Batch | Reinhart et al. (2015) |
23.9 | 0.7 | >50 | >5.8 | 345 | Fed-batch | Reinhart et al. (2015) | |
1.3 | 0.8 | >2 | 0.04 | 2 | Batch | Lee et al. (2005) | |
27–33.5 | n.a. | >2 | 0.09–0.015 | 58–72 | Perfusion | Lee et al. (2005) | |
>10 | 0.7 | 57 | >1 | 85 | Fed-batch | Zboray et al. (2015) | |
25; 26 | n.a. | 35; 49 | 10; 13 | 530; 730 | Fed-batch | Huang et al. (2010) | |
n.a. | n.a. | n.a. | 9.8 | 470 | Fed-batch | Luan et al. (2006) | |
>200 | n.a. | 10–15 | n.a. | n.a. | Perfusion | Clincke et al. (2011) | |
<110 | n.a. | 9–13 | n.a. | n.a. | Perfusion | Clincke et al. (2013) | |
PER.C6 | 5 | 0.5 | n.a. | 0.3–0.5 | 42 | Batch | Jones et al. (2003) |
>4 | 0.5 | 14–24 | 0.39 | n.a. | Batch | De Kruif et al. (2010) | |
n.a. | n.a. | n.a. | 8 | n.a. | Fed-batch | Kuczewski et al. (2011) | |
≥150 | n.a. | n.a. | 27a | n.a. | Perfusiona | Kuczewski et al. (2011) | |
HEK 293b | n.a. | n.a. | n.a. | ≤0.3 | 43 | Batch | Hasegawa et al. (2014) |
>2 | n.a. | 20 | 0.2 | 20 | Batch | Nallet et al. (2012) | |
2–4 | n.a. | 5–10 | 0.12–0.14c | 24–28 | Batch | Jäger et al. (2013) | |
6–8 | n.a. | 5–10 | 0.1–0.6c | <100 | Fed-batch | Jäger et al. (2013) | |
NS0 | 0.6–1.0 | 0.3–0.6 | 20–50 | 0.1–0.2 | 13–17 | Batch | Ho et al. (2012) |
2.3 | 0.6–1.0 | 8–20 | 0.07 | 14 | Batch | Spens and Häggström (2007) | |
2.3–9.9 | 1.0 | 8–20 | 0.1–0.8 | 19–67 | Fed-batch | Spens and Häggström (2007) | |
2.4 | 0.5 | 1.9–13.4 | 0.24 | 17 | Fed-batch | Stansfield et al. (2007) |
Values for the specific growth rate refer to the exponential growth phase
n .a. not available
aProduct and cell retention in an extreme density bioreactor
bTransient mAb expression
cProduct was a scFv-Fc antibody fragment